Open AccessKidney damage by COVID-19 and rationale for extracorporeal therapies
Author(s) -
Uzma Mehreen,
Asad Ali,
Aisha Khatoon,
Nishat Zafar,
Qaisar Tanveer,
Irha Basit
Publication year - 2020
Publication title -
biomedical research and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 1
ISSN - 2198-4093
DOI - 10.15419/bmrat.v7i10.644
Subject(s) - covid-19 , extracorporeal , medicine , kidney , intensive care medicine , disease , coronavirus , kidney disease , immunology , bioinformatics , virology , pathology , infectious disease (medical specialty) , biology , outbreak
Without doubt, there is some involvement of the kidney in novel coronavirus disease (COVID-19), which is responsible for multiple organ dysfunctions resulting in severe complications in the human body. This newly discovered COVID-19 has incited panic globally. However, the role of kidney involvement in the novel COVID-19 disease is still unclear. In this commentary, we discuss the various pathways involved in kidney damage by COVID-19, and the rationale for extracorporeal support with various blood purification strategies in critically ill people with COVID 19.